These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 28367447)

  • 21. Combined Effects of Vitamin D Status, Renal Function and Age on Serum Parathyroid Hormone Levels.
    Niculescu DA; Deacu LG; Caragheorgheopol A; Popescu N; Ghemigian A; Procopiuc C; Rosca R; Poiana C
    Front Endocrinol (Lausanne); 2021; 12():657991. PubMed ID: 33995282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid Hormone Levels Are Independently Associated with eGFR and Albuminuria: The Dong-gu Study.
    Choi SW; Kweon SS; Lee YH; Ryu SY; Choi JS; Nam HS; Park KS; Kim SA; Shin MH
    J Nutr Sci Vitaminol (Tokyo); 2018; 64(1):18-25. PubMed ID: 29491268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparisons of serum vitamin D levels, status, and determinants in populations with and without chronic kidney disease not requiring renal dialysis: a 24-hour urine collection population-based study.
    Guessous I; McClellan W; Kleinbaum D; Vaccarino V; Zoller O; Theler JM; Paccaud F; Burnier M; Bochud M;
    J Ren Nutr; 2014 Sep; 24(5):303-12. PubMed ID: 25030223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
    Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
    Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008-2011.
    Lee YH; Kim JE; Roh YH; Choi HR; Rhee Y; Kang DR; Lim SK
    J Clin Endocrinol Metab; 2014 Oct; 99(10):3879-88. PubMed ID: 24878040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3.
    Shardlow A; McIntyre NJ; Fluck RJ; McIntyre CW; Taal MW
    BMJ Open; 2017 Aug; 7(8):e016528. PubMed ID: 28838895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of sevelamer to examine the role of intraluminal phosphate in the pathogenesis of secondary hyperparathyroidism.
    Phelps KR; Stote KS; Mason D
    Clin Nephrol; 2014 Sep; 82(3):191-201. PubMed ID: 25079864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deviations from the expected relationship between serum FGF23 and other markers in children with CKD: a cross-sectional study.
    Liu D; Alvarez-Elías AC; Wile B; Belostotsky V; Filler G
    BMC Nephrol; 2017 Jun; 18(1):204. PubMed ID: 28659167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum vitamin D in obese and overweight subjects according to estimated glomerular filtration rate.
    Kitsos A; Dounousi E; Kalaitzidis R; Challa A; Siamopoulos KC; Tigas S
    Hormones (Athens); 2018 Jun; 17(2):237-246. PubMed ID: 29858844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
    Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
    Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of some medications given to CKD patients on vitamin D levels.
    Yuste C; Quiroga B; de Vinuesa SG; Goicoechea MA; Barraca D; Verdalles U; Luño J
    Nefrologia; 2015; 35(2):150-6. PubMed ID: 26300508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
    Marsell R; Grundberg E; Krajisnik T; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
    Eur J Endocrinol; 2008 Jan; 158(1):125-9. PubMed ID: 18166826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperphosphatemia with elevated serum PTH and FGF23, reduced 1,25(OH)
    Kritmetapak K; Losbanos L; Berent TE; Ashrafzadeh-Kian SL; Algeciras-Schimnich A; Hines JM; Singh RJ; Kumar R
    BMC Nephrol; 2021 Mar; 22(1):114. PubMed ID: 33784965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
    Jungert A; Neuhäuser-Berthold M
    Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol?
    Ghazali A; Fardellone P; Pruna A; Atik A; Achard JM; Oprisiu R; Brazier M; Remond A; Morinière P; Garabedian M; Eastwood J; Fournier A
    Kidney Int; 1999 Jun; 55(6):2169-77. PubMed ID: 10354266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary Hyperparathyroidism in Patients with Biliopancreatic Diversion After 10 Years of Follow-up, and Relationship with Vitamin D and Serum Calcium.
    Alejo Ramos M; Cano Rodríguez IM; Urioste Fondo AM; Pintor de la Maza B; Barajas Galindo DE; Fernández Martínez P; González Herráez L; González de Francisco T; Ballesteros Pomar MD
    Obes Surg; 2019 Mar; 29(3):999-1006. PubMed ID: 30523538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.